Ryutaro Arita

722 total citations
57 papers, 392 citations indexed

About

Ryutaro Arita is a scholar working on Pharmacology, Physiology and Complementary and alternative medicine. According to data from OpenAlex, Ryutaro Arita has authored 57 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 13 papers in Physiology and 12 papers in Complementary and alternative medicine. Recurrent topics in Ryutaro Arita's work include Pharmacological Effects of Natural Compounds (24 papers), Plant-based Medicinal Research (10 papers) and Pathogenesis and Treatment of Hiccups (7 papers). Ryutaro Arita is often cited by papers focused on Pharmacological Effects of Natural Compounds (24 papers), Plant-based Medicinal Research (10 papers) and Pathogenesis and Treatment of Hiccups (7 papers). Ryutaro Arita collaborates with scholars based in Japan, United States and France. Ryutaro Arita's co-authors include Shin Takayama, Tadashi Ishii, Akiko Kikuchi, Minoru Ohsawa, Tetsuhiro Yoshino, Rie Ono, Natsumi Saito, Yasuhiro Komatsu, Mitsuru Honda and Hiroaki Asou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Frontiers in Pharmacology.

In The Last Decade

Ryutaro Arita

47 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryutaro Arita Japan 11 169 94 77 57 45 57 392
Rensong Yue China 13 71 0.4× 41 0.4× 68 0.9× 165 2.9× 43 1.0× 52 452
Stefania Esposito Italy 9 41 0.2× 36 0.4× 18 0.2× 44 0.8× 15 0.3× 17 373
Alessandra Miccono Italy 8 31 0.2× 34 0.4× 120 1.6× 60 1.1× 34 0.8× 10 391
Pui Kuan Cheong Hong Kong 13 50 0.3× 66 0.7× 69 0.9× 138 2.4× 18 0.4× 27 680
Kung‐Chang Hwang Taiwan 11 73 0.4× 182 1.9× 86 1.1× 75 1.3× 71 1.6× 22 589
Mei Feng China 13 26 0.2× 66 0.7× 68 0.9× 78 1.4× 42 0.9× 41 420
Yeşim Tunçok Türkiye 13 78 0.5× 10 0.1× 36 0.5× 78 1.4× 29 0.6× 61 452
Mozhdeh Zabihiyeganeh Iran 9 59 0.3× 28 0.3× 39 0.5× 64 1.1× 15 0.3× 32 423
Shi-Bing Liang China 10 56 0.3× 83 0.9× 32 0.4× 66 1.2× 10 0.2× 28 274
Craig D. Logemann United States 6 41 0.2× 99 1.1× 56 0.7× 53 0.9× 52 1.2× 11 398

Countries citing papers authored by Ryutaro Arita

Since Specialization
Citations

This map shows the geographic impact of Ryutaro Arita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryutaro Arita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryutaro Arita more than expected).

Fields of papers citing papers by Ryutaro Arita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryutaro Arita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryutaro Arita. The network helps show where Ryutaro Arita may publish in the future.

Co-authorship network of co-authors of Ryutaro Arita

This figure shows the co-authorship network connecting the top 25 collaborators of Ryutaro Arita. A scholar is included among the top collaborators of Ryutaro Arita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryutaro Arita. Ryutaro Arita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Noda, Aoi, Ryutaro Arita, Taku Obara, et al.. (2025). Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy. Pharmacoepidemiology and Drug Safety. 34(11). e70251–e70251.
3.
Noda, Aoi, Taku Obara, Satoko Suzuki, et al.. (2024). Risk of Major Congenital Malformations Associated with the Use of Japanese Traditional (Kampo) Medicine Containing Ephedra During the First Trimester of Pregnancy. Drugs - Real World Outcomes. 11(2). 263–272. 3 indexed citations
4.
Ono, Rie, Shin Takayama, Natsumi Saito, et al.. (2024). A Case Series of Post-COVID Conditions with Fatigability Treated with Saikokeishito. An Official Journal of the Japan Primary Care Association. 47(2). 49–55. 1 indexed citations
5.
Noda, Aoi, Ryutaro Arita, Taku Obara, et al.. (2024). The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study. Pharmacoepidemiology and Drug Safety. 33(10). e70033–e70033. 2 indexed citations
6.
Abe, Michiaki, Takuhiro Yamaguchi, S. Koshiba, et al.. (2024). Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study. Clinical and Experimental Nephrology. 28(11). 1134–1154.
7.
Suzuki, Tomoko, Akiko Kikuchi, Akiyo Kaneko, et al.. (2023). A review of frequently used Kampo prescriptions: Part 2—Hangekobokuto. Traditional & Kampo Medicine. 10(2). 103–119. 6 indexed citations
8.
Takayama, Shin, et al.. (2023). Review of frequently used Kampo prescriptions: Part 4, Ninjin'yoeito. Traditional & Kampo Medicine. 10(3). 224–252. 6 indexed citations
9.
Ono, Rie, Ryutaro Arita, Shin Takayama, et al.. (2023). Progress and treatment of “long COVID” in non‐hospitalized patients: A single‐center retrospective cohort study. Traditional & Kampo Medicine. 10(2). 150–158. 4 indexed citations
10.
Akaishi, Tetsuya, Satoko Suzuki, Rie Ono, et al.. (2023). Predictors for the Development of Hypoxia or Prolonged Acute Symptoms among Non-Hospitalized Mild-to-Moderate Patients with Coronavirus Disease 2019. The Tohoku Journal of Experimental Medicine. 260(3). 231–244.
11.
Yamaguchi, Hideaki, Tetsuhiro Yoshino, Hiroaki Oizumi, et al.. (2023). A review of frequently used Kampo prescriptions. Part 3. Yokukansan. Traditional & Kampo Medicine. 10(3). 197–223. 8 indexed citations
12.
Yoshino, Tetsuhiro, et al.. (2023). The Integration of Traditional Medicine with Conventional Biomedicine: A Narrative Review of the Japanese Perspective. Journal of Integrative and Complementary Medicine. 29(6-7). 372–379. 6 indexed citations
13.
14.
Takayama, Shin, Ryutaro Arita, & Tadashi Ishii. (2022). Case Report: Prolonged Anorexia With Nausea Caused by Immune Checkpoint Inhibitors for Malignant Melanoma Treated Using Kampo Medicines Bukuryoingohangekobokuto and Ninjin’yoeito. Frontiers in Pharmacology. 13. 870823–870823. 5 indexed citations
15.
Takayama, Shin, Ryutaro Arita, Akiko Kikuchi, & Tadashi Ishii. (2021). Bukuryoingohangekobokuto may improve recurrent aspiration pneumonia in patients with brain damage and reduce the caregiver burden. Journal of Family Medicine and Primary Care. 10(1). 558–560. 3 indexed citations
16.
Suzuki, Satoko, Taku Obara, Tomofumi Ishikawa, et al.. (2021). Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database. Frontiers in Nutrition. 8. 762895–762895. 15 indexed citations
17.
Arita, Ryutaro, Shin Takayama, Hiroshi Okamoto, et al.. (2020). Exploratory study of clinical effectiveness and safety of TJ-116 bukuryoingohangekobokuto for anxiety and postoperative water brash in esophageal cancer patients (TJ116E). Medicine. 99(22). e20317–e20317. 2 indexed citations
18.
Takayama, Shin, Naoki Tomita, Ryutaro Arita, et al.. (2020). Kampo Medicine for Various Aging-Related Symptoms: A Review of Geriatric Syndrome. Frontiers in Nutrition. 7. 86–86. 18 indexed citations
19.
Arita, Ryutaro, et al.. (2019). The Current Status and Evolution of Clinical Trials on Kampo Medicine : Examining “Evidence Reports of Kampo Treatment”. Kampo Medicine. 70(4). 419–429. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rensong Yue Breakdown of academic impact, for papers by Stefania Esposito Breakdown of academic impact, for papers by Alessandra Miccono Breakdown of academic impact, for papers by Pui Kuan Cheong Breakdown of academic impact, for papers by Kung‐Chang Hwang Breakdown of academic impact, for papers by Mei Feng Breakdown of academic impact, for papers by Yeşim Tunçok Breakdown of academic impact, for papers by Mozhdeh Zabihiyeganeh Breakdown of academic impact, for papers by Shi-Bing Liang Breakdown of academic impact, for papers by Craig D. Logemann
Rankless by CCL
2026